Aza-peptidyl Michael acceptor and epoxide inhibitors--potent and selective inhibitors of Schistosoma mansoni and Ixodes ricinus legumains (asparaginyl endopeptidases).
暂无分享,去创建一个
Jan Dvorák | Fanuel Muindi | Daniel Sojka | J. Dvorak | C. Fagan | J. McKerrow | C. Caffrey | J. Powers | P. Kopáček | James H McKerrow | Conor R Caffrey | D. Sojka | Petr Kopácek | Elizabeth Hansell | James C Powers | Asli Ovat | Crystal Fagan | Michelle Brouner | F. Muindi | E. Hansell | Asli Ovat | Michelle Brouner | M. Brouner
[1] A. Barrett,et al. Inhibition of Mammalian Legumain by Michael Acceptors and AzaAsn-Halomethylketones , 2002, Biological chemistry.
[2] K. Ye,et al. Mice lacking asparaginyl endopeptidase develop disorders resembling hemophagocytic syndrome , 2009, Proceedings of the National Academy of Sciences.
[3] J. Dvorak,et al. Aza-peptidyl Michael acceptors. A new class of potent and selective inhibitors of asparaginyl endopeptidases (legumains) from evolutionarily diverse pathogens. , 2008, Journal of medicinal chemistry.
[4] Xiaohong Huang,et al. Characterization of asparaginyl endopeptidase, legumain induced by blood feeding in the ixodid tick Haemaphysalis longicornis. , 2007, Insect biochemistry and molecular biology.
[5] J. Mikolajczyk,et al. Design, synthesis, and evaluation of aza-peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. , 2006, Journal of medicinal chemistry.
[6] M. Bogyo,et al. Identification of a cDNA encoding an active asparaginyl endopeptidase of Schistosoma mansoni and its expression in Pichia pastoris 1 , 2000, FEBS letters.
[7] C. Lowe,et al. A stepwise synthesis of triazine-based macrocyclic scaffolds , 2000 .
[8] Jan Dvorák,et al. A Multienzyme Network Functions in Intestinal Protein Digestion by a Platyhelminth Parasite* , 2006, Journal of Biological Chemistry.
[9] J. Nowick,et al. Synthesis of Peptide Isocyanates and Isothiocyanates. , 1996, The Journal of organic chemistry.
[10] S. Ishii. Legumain: asparaginyl endopeptidase. , 1994, Methods in enzymology.
[11] A. H. Davis,et al. Cloning and gene expression of Schistosoma mansoni protease. , 1987, The Journal of biological chemistry.
[12] Marcel Tanner,et al. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. , 2006, The Lancet. Infectious diseases.
[13] P. Vandenabeele,et al. Inhibition of papain-like cysteine proteases and legumain by caspase-specific inhibitors: when reaction mechanism is more important than specificity , 2003, Cell Death and Differentiation.
[14] J. McKerrow,et al. Cysteine Protease Inhibitors Cure an Experimental Trypanosoma cruzi Infection , 1998, Journal of Experimental Medicine.
[15] M. Bogyo,et al. IrAE: an asparaginyl endopeptidase (legumain) in the gut of the hard tick Ixodes ricinus. , 2007, International journal for parasitology.
[16] J. Dvorak,et al. Aza-peptide Michael acceptors: a new class of inhibitors specific for caspases and other clan CD cysteine proteases. , 2004, Journal of medicinal chemistry.
[17] C. Niemann,et al. The Interaction of Ethyl 1-Acetyl-2-benzylcarbazate with alpha-Chymotrypsin1 , 1961 .
[18] Jun Kong,et al. MEROPS: the peptidase database. , 2004, Nucleic acids research.
[19] M. Nishimura,et al. Molecular characterization of a vacuolar processing enzyme related to a putative cysteine proteinase of Schistosoma mansoni. , 1993, The Plant cell.
[20] E. Fikrig,et al. Borrelia burgdorferi--traveling incognito? , 2006, Microbes and infection.
[21] J. Powers,et al. Irreversible Inhibitors of Serine, Cysteine, and Threonine Proteases , 2003 .
[22] S. Reddy,et al. Identification of Human Asparaginyl Endopeptidase (Legumain) as an Inhibitor of Osteoclast Formation and Bone Resorption* , 1999, The Journal of Biological Chemistry.
[23] M. Bogyo,et al. Functional expression and characterization of Schistosoma mansoni cathepsin B and its trans-activation by an endogenous asparaginyl endopeptidase. , 2003, Molecular and biochemical parasitology.
[24] D. Turk,et al. E-64 analogues as inhibitors of cathepsin B. On the role of the absolute configuration of the epoxysuccinyl group. , 1997, Bioorganic & Medicinal Chemistry.
[25] J. Mikolajczyk,et al. Design, synthesis, and evaluation of aza-peptide epoxides as selective and potent inhibitors of caspases-1, -3, -6, and -8. , 2004, Journal of medicinal chemistry.
[26] Matthew Bogyo,et al. Substrate specificity of schistosome versus human legumain determined by P1-P3 peptide libraries. , 2002, Molecular and biochemical parasitology.
[27] Cheng Liu,et al. Overexpression of legumain in tumors is significant for invasion/metastasis and a candidate enzymatic target for prodrug therapy. , 2003, Cancer research.
[28] A. Hamilton,et al. Cyclopiperazines: A new approach to chiral macrocyclic receptors☆ , 1986 .
[29] N. Rawlings,et al. Cloning, Isolation, and Characterization of Mammalian Legumain, an Asparaginyl Endopeptidase* , 1997, The Journal of Biological Chemistry.
[30] A. Barrett,et al. Pig kidney legumain: an asparaginyl endopeptidase with restricted specificity. , 1999, The Biochemical journal.
[31] M. Sajid,et al. Blood 'n' guts: an update on schistosome digestive peptidases. , 2004, Trends in parasitology.
[32] J. Nowick,et al. An improved method for the synthesis of enantiomerically pure amino acid ester isocyanates , 1992 .
[33] R. Abeles,et al. Cysteine protease inhibition by azapeptide esters. , 1992, Journal of medicinal chemistry.
[34] D. Rich,et al. Mechanistic studies on the inactivation of papain by epoxysuccinyl inhibitors. , 1996, Journal of medicinal chemistry.
[35] H. Yokosawa,et al. Asparaginyl endopeptidase of jack bean seeds. Purification, characterization, and high utility in protein sequence analysis. , 1993, The Journal of biological chemistry.
[36] C. Caffrey,et al. Parasites & Vectors BioMed Central , 2008 .
[37] O. Meth–Cohn,et al. A stereocontrolled approach to electrophilic epoxides , 1988 .
[38] B. Manoury,et al. Novel Cell-Permeable Acyloxymethylketone Inhibitors of Asparaginyl Endopeptidase , 2003, Biological chemistry.